Polycystic ovary syndrome

Polycystic ovary syndrome
Other namesHyperandrogenic anovulation (HA),[1] Stein-Leventhal syndrome[2]
A polycystic ovary
SpecialtyGynecology, endocrinology
SymptomsIrregular menstrual periods, heavy periods, excess hair, acne, pelvic pain, difficulty getting pregnant, patches of thick, darker, velvety skin[3]
ComplicationsType 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, endometrial cancer[4]
DurationLong term[5]
CausesGenetic and environmental factors[6][7]
Risk factorsObesity, not enough exercise, family history[8]
Diagnostic methodBased on anovulation, high androgen levels, ovarian cysts[4]
Differential diagnosisAdrenal hyperplasia, hypothyroidism, high blood levels of prolactin[9]
TreatmentWeight loss, exercise[10][11]
MedicationBirth control pills, metformin, GLP-1, anti-androgens[12]
Frequency2% to 20% of women of childbearing age[8][13]

Polycystic ovary syndrome, or polycystic ovarian syndrome (PCOS), is the most common endocrine disorder in women of reproductive age.[14] The syndrome is named after cysts which form on the ovaries of some women with this condition, though this is not a universal symptom, and not the underlying cause of the disorder.[15][16]

Women with PCOS may experience irregular menstrual periods, heavy periods, excess hair, acne, pelvic pain, difficulty getting pregnant, and patches of thick, darker, velvety skin.[3] The primary characteristics of this syndrome include: hyperandrogenism, anovulation, insulin resistance, and neuroendocrine disruption.[17]

A review of international evidence found that the prevalence of PCOS could be as high as 26% among some populations, though ranges between 4% and 18% are reported for general populations.[18][19][20]

The exact cause of PCOS remains uncertain, and treatment involves management of symptoms using medication.[19]

  1. ^ Kollmann M, Martins WP, Raine-Fenning N (2014). "Terms and thresholds for the ultrasound evaluation of the ovaries in women with hyperandrogenic anovulation". Human Reproduction Update. 20 (3): 463–464. doi:10.1093/humupd/dmu005. PMID 24516084.
  2. ^ Legro RS (2017). "Stein-Leventhal syndrome". Encyclopedia Britannica. Archived from the original on 29 October 2020. Retrieved 30 January 2021.[better source needed]
  3. ^ a b Cite error: The named reference NICHD What are the symptoms of PCOS? was invoked but never defined (see the help page).
  4. ^ a b "Polycystic Ovary Syndrome (PCOS): Condition Information". National Institute of Child Health and Human Development. January 31, 2017. Archived from the original on 22 October 2018. Retrieved 19 November 2018.
  5. ^ Cite error: The named reference NICHD Is there a cure for PCOS? was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference De2016 was invoked but never defined (see the help page).
  7. ^ Cite error: The named reference Endo2006 was invoked but never defined (see the help page).
  8. ^ a b Cite error: The named reference NICHD What causes PCOS? was invoked but never defined (see the help page).
  9. ^ Cite error: The named reference NICHD How do health care providers diagnose PCOS? was invoked but never defined (see the help page).
  10. ^ Cite error: The named reference Mor2015 was invoked but never defined (see the help page).
  11. ^ Cite error: The named reference Gia2009 was invoked but never defined (see the help page).
  12. ^ Cite error: The named reference NIH2014Tx1 was invoked but never defined (see the help page).
  13. ^ Cite error: The named reference Lub2013 was invoked but never defined (see the help page).
  14. ^ Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E (November 2015). "American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1". Endocrine Practice. 21 (11): 1291–1300. doi:10.4158/EP15748.DSC. PMID 26509855.
  15. ^ Dunaif A, Fauser BC (November 2013). "Renaming PCOS--a two-state solution". The Journal of Clinical Endocrinology and Metabolism. 98 (11): 4325–4328. doi:10.1210/jc.2013-2040. PMC 3816269. PMID 24009134. Around 20% of European women have polycystic ovaries (the prevalence is even higher in some other populations) but approximately two-thirds of these women do not have PCOS
  16. ^ Khan MJ, Ullah A, Basit S. Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Appl Clin Genet. 2019 Dec 24;12:249-260. doi: 10.2147/TACG.S200341. PMID 31920361; PMCID: PMC6935309.
  17. ^ Crespo RP, Bachega TA, Mendonça BB, Gomes LG (June 2018). "An update of genetic basis of PCOS pathogenesis". Archives of Endocrinology and Metabolism. 62 (3): 352–361. doi:10.20945/2359-3997000000049. PMC 10118782. PMID 29972435. S2CID 49681196.
  18. ^ Muscogiuri G, Altieri B, de Angelis C, Palomba S, Pivonello R, Colao A, et al. (September 2017). "Shedding new light on female fertility: The role of vitamin D". Reviews in Endocrine & Metabolic Disorders. 18 (3): 273–283. doi:10.1007/s11154-017-9407-2. PMID 28102491. S2CID 33422072.
  19. ^ a b Lentscher JA, Slocum B, Torrealday S (March 2021). "Polycystic Ovarian Syndrome and Fertility". Clinical Obstetrics and Gynecology. 64 (1): 65–75. doi:10.1097/GRF.0000000000000595. PMID 33337743. S2CID 229323594.
  20. ^ Wolf WM, Wattick RA, Kinkade ON, Olfert MD (November 2018). "Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity". International Journal of Environmental Research and Public Health. 15 (11): 2589. doi:10.3390/ijerph15112589. PMC 6266413. PMID 30463276. indigenous Australian women could have a prevalence as high as 26%

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search